Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHSBC Holdings Regulatory News (HSBA)

Share Price Information for HSBC Holdings (HSBA)

Share Price is delayed by 15 minutes
Get Live Data
1,278.40    -33.00 (-2.52%)
Bid:
1,278.40
Ask:
1,278.80
Spread: 0.40 (0.031%)
Market Cap: £219.22b
HSBA Live PriceLast checked at - London Stock Exchange

Intraday HSBC Holdings Share Chart

Pre Stabilisation Notice

6 May 2025 08:24

RNS Number : 4728H
HSBC Bank plc
06 May 2025
 

6th May 2025

 

HSBC Holdings

Pre Stabilisation Notice

HSBC (contact: syndexecution@noexternalmail.hsbc.com) hereby gives notice, as Stabilisation Coordinator, that the Stabilisation Manager(s) named below may stabilise the offer of the following securities

The securities:

Issuer:

HSBC Holdings

Guarantor (if any):

NA 

Aggregate nominal amount:

EUR Benchmark

Description:

Fixed rate 9NC8

Offer price:

TBC

Other offer terms:

Stabilisation:

Stabilising Manager(s):

HSBC Bank plc , ABN Amro, CaixaBank , CIBC Capital markets, Commerzbank , Danske Bank , Nordea

Stabilisation period expected to start on:

6th May 2025

Stabilisation period expected to end no later than:

6th June 2025

Existence, maximum size & conditions of use of over-allotment facility[1]:

5% of the aggregate nominal amount

Stabilisation Venue(s)

Over the counter (OTC)

 

In connection with the offer of the above securities, the Stabilisation Manager(s) may over-allot the securities or effect transactions with a view to supporting the market price of the securities at a level higher than that which might otherwise prevail. However, there is no assurance that the Stabilisation Manager(s) will take any stabilisation action and any stabilisation action, if begun, may be ended at any time. Any stabilisation action or over-allotment shall be conducted in accordance with all applicable laws and rules.

This announcement is for information purposes only and does not constitute an invitation or offer to underwrite, subscribe for or otherwise acquire or dispose of any securities of the Issuer in any jurisdiction.

 

In addition, if and to the extent that this announcement is communicated in, or the offer of the securities to which it relates is made in, any EEA Member State before the publication of a prospectus in relation to the securities which has been approved by the competent authority in that Member State in accordance with the Regulation (EU) 2017/1129 (the "Prospectus Regulation") (or which has been approved by a competent authority in another Member State and notified to the competent authority in that Member State in accordance with the Prospectus Regulation), this announcement and the offer are only addressed to and directed at persons in that Member State who are qualified investors within the meaning of the Prospectus Regulation (or who are other persons to whom the offer may lawfully be addressed) and must not be acted on or relied on by other persons in that Member State.

 

This announcement and the offer of the securities to which it relates are only addressed to and directed at persons outside the United Kingdom and persons in the United Kingdom who have professional experience in matters related to investments or who are high net worth persons within article 12(5) of the Financial Services and Markets Act 2000 (Financial Promotion) Order 2005 and must not be acted on or relied on by other persons in the United Kingdom.

 

This announcement is not an offer of securities for sale into the United States. The securities have not been, and will not be, registered under the United States Securities Act of 1933 and may not be offered or sold in the United States absent registration or an exemption from registration. There will be no public offer of securities in the United States.


[1] Please note that the existence and the maximum size of any greenshoe option, the exercise period of the greenshoe option and any conditions for exercise of the greenshoe option must also be disclosed, if such option exists. In addition, the exercise of the greenshoe option must be disclosed to the public promptly, together with all appropriate details, including in particular the date of exercise and the number and nature of securities involved 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
STAZZGGKNVFGKZG
Date   Source Headline
9th Nov 202310:31 amRNSDirector/PDMR Shareholding
9th Nov 202310:30 amRNSOverseas Regulatory Announcement - Grant of Awards
8th Nov 20235:28 pmRNSTransaction in Own Shares
7th Nov 20235:29 pmRNSTransaction in Own Shares
6th Nov 20235:45 pmRNSTransaction in Own Shares
3rd Nov 20235:30 pmRNSTransaction in Own Shares
3rd Nov 20234:00 pmRNSDirector/PDMR Shareholding
3rd Nov 20239:30 amRNSResponse to voting results at 2023 AGM
2nd Nov 20235:45 pmRNSTransaction in Own Shares
1st Nov 20235:27 pmRNSTransaction in Own Shares
31st Oct 20235:30 pmRNSHSBC Holdings PLC – Share buy-back
31st Oct 20234:30 pmRNSTotal Voting Rights
31st Oct 20233:45 pmRNSPublication of base prospectus supplement
30th Oct 20235:00 pmRNSCancellation of Treasury Shares
30th Oct 20234:30 pmRNSDirector/PDMR Shareholding
30th Oct 20237:00 amRNSHSBC Holdings PLC 3Q23 Earnings Release
30th Oct 20237:00 amRNS3Q23 Earnings - webcast + conference call
26th Oct 20236:29 pmRNSTransaction in own shares & conclusion of buy-back
26th Oct 20237:00 amRNSTransaction in Own Shares
24th Oct 20236:17 pmRNSTransaction in Own Shares
23rd Oct 20236:27 pmRNSTransaction in Own Shares
20th Oct 20236:29 pmRNSTransaction in Own Shares
20th Oct 20238:46 amRNSHolding(s) in Company
19th Oct 20236:12 pmRNSTransaction in Own Shares
18th Oct 20236:08 pmRNSTransaction in Own Shares
18th Oct 202312:01 pmRNSHSBC - Redemption Notice and Listing Cancellation
17th Oct 20236:13 pmRNSTransaction in Own Shares
17th Oct 20239:30 amRNSOverseas Regulatory Announcement - Board Meeting
16th Oct 20235:59 pmRNSTransaction in Own Shares
13th Oct 20234:30 pmRNSTransaction in Own Shares
13th Oct 20239:00 amRNSPost Stabilisation Notice
12th Oct 20234:40 pmRNSTransaction in Own Shares
11th Oct 20234:30 pmRNSTransaction in Own Shares
11th Oct 20231:00 pmRNSOverseas Regulatory Announcement - Grant of Awards
10th Oct 20234:45 pmRNSTransaction in Own Shares
6th Oct 20236:11 pmRNSTransaction in Own Shares
5th Oct 20236:08 pmRNSTransaction in Own Shares
5th Oct 20233:45 pmRNSNotice of redemption
4th Oct 20236:00 pmRNSTransaction in Own Shares
3rd Oct 20236:08 pmRNSTransaction in Own Shares
2nd Oct 20236:08 pmRNSTransaction in Own Shares
2nd Oct 20234:30 pmRNSTotal Voting Rights
28th Sep 20236:21 pmRNSTransaction in Own Shares
28th Sep 202310:31 amRNSDirector/PDMR Shareholding
28th Sep 202310:30 amRNSOverseas Regulatory Announcement- Grant of Options
27th Sep 20236:12 pmRNSTransaction in Own Shares
26th Sep 20236:27 pmRNSTransaction in Own Shares
26th Sep 20235:00 pmRNSIssuance of subordinated unsecured notes
26th Sep 20234:30 pmRNSDirector/PDMR Shareholding
25th Sep 20236:22 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.